Walleye Capital’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.74M | Buy |
708,946
+150,104
| +27% | +$1.21M | 0.02% | 368 |
|
|
2025
Q1 | $4.68M | Buy |
558,842
+519,863
| +1,334% | +$4.36M | 0.02% | 370 |
|
|
2024
Q4 | $309K | Sell |
38,979
-92,688
| -70% | -$734K | ﹤0.01% | 1354 |
|
|
2024
Q3 | $1.1M | Buy |
+131,667
| New | +$1.1M | ﹤0.01% | 1007 |
|
|
2024
Q2 | – | Sell |
-78,098
| Closed | -$473K | – | 2633 |
|
|
2024
Q1 | $473K | Buy |
+78,098
| New | +$473K | ﹤0.01% | 1412 |
|
|
2020
Q1 | – | Sell |
-75,900
| Closed | -$366K | – | 519 |
|
|
2019
Q4 | $366K | Buy |
75,900
+35,473
| +88% | +$171K | 0.02% | 248 |
|
|
2019
Q3 | $117K | Buy |
+40,427
| New | +$117K | 0.01% | 268 |
|
|
2019
Q2 | – | Sell |
-100
| Closed | -$1K | – | 492 |
|
|
2019
Q1 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 358 |
|